Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126949881 | 12694988 | 1 | I | 20160504 | 20160527 | 20160829 | 20160829 | EXP | US-BAYER-2016-104009 | BAYER | 68.00 | YR | E | M | Y | 0.00000 | 20160829 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126949881 | 12694988 | 1 | PS | NEXAVAR | SORAFENIB | 1 | Oral | 200 MG, BID | 9600 | MG | BXH9XU3 | 21923 | 200 | MG | FILM-COATED TABLET | BID | |||
| 126949881 | 12694988 | 2 | SS | NEXAVAR | SORAFENIB | 1 | Oral | 400 MG, BID | 9600 | MG | BXH9XU3 | 21923 | 400 | MG | FILM-COATED TABLET | BID | |||
| 126949881 | 12694988 | 3 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 126949881 | 12694988 | 4 | C | MELOXICAM. | MELOXICAM | 1 | 0 | ||||||||||||
| 126949881 | 12694988 | 5 | C | HYDROXYZINE | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126949881 | 12694988 | 6 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | ||||||||||||
| 126949881 | 12694988 | 7 | C | METOPROLOL. | METOPROLOL | 1 | 0 | ||||||||||||
| 126949881 | 12694988 | 8 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126949881 | 12694988 | 9 | C | TRAMADOL. | TRAMADOL | 1 | 0 | ||||||||||||
| 126949881 | 12694988 | 10 | C | WARFARIN | WARFARIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126949881 | 12694988 | 1 | Hepatic cancer |
| 126949881 | 12694988 | 2 | Hepatic cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126949881 | 12694988 | OT |
| 126949881 | 12694988 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126949881 | 12694988 | Anaemia | |
| 126949881 | 12694988 | Anal fissure | |
| 126949881 | 12694988 | Anal haemorrhage | |
| 126949881 | 12694988 | Chest pain | |
| 126949881 | 12694988 | Epistaxis | |
| 126949881 | 12694988 | Pruritus | |
| 126949881 | 12694988 | Underdose | |
| 126949881 | 12694988 | Volume blood decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126949881 | 12694988 | 1 | 20160504 | 20160527 | 0 | |
| 126949881 | 12694988 | 2 | 201605 | 0 |